Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology News Central (ONC)
“A patient who is considered neutropenic, if they spike a low-grade temperature of 100.4, they can go from being alive and well to dead in three hours,” Palmeri testified, explaining why oncologists ultimately withdrew acute hematology services after documenting that nurses “were not checking temperature in the time frames that they’re supposed to check.”
Hematology/Oncology December 1st 2025
MDLinx
Silent inactivation (where neutralizing antibodies reduce enzymatic activity without clinical symptoms) can go undetected without therapeutic drug monitoring, leading to subtherapeutic asparagine depletion and increased relapse risk.
Hematology December 1st 2025
Guideline Central
PORT is recommended for patients with cSCC having close or positive margins that cannot be corrected with further surgery (secondary to morbidity or adverse cosmetic outcome). In patients with cSCC, PORT is recommended for T3 and T4 tumors—both strong recommendations with moderate to low evidence quality.
Dermatology December 1st 2025
What began as a seemingly routine migraine case quickly unraveled into a devastating example of how fear, misinformation, and delayed care can transform a curable condition into a terminal diagnosis.
Hematology/Oncology November 19th 2025
Providers nationwide are experiencing an uptick in health plans denying payments by improperly asserting that providers are not coding their claims correctly.
Hematology/Oncology November 17th 2025
The research suggests that patients with cancer who previously received preventative prescriptions even without pain may now be less likely to receive a prescription until they begin reporting pain.